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Abstract 
Introduction: Clinical and epidemiological data on suspected congenital Zika syndrome (CZS) cases from southern Mato 
Grosso (MT) in Brazil during the Zika virus (ZIKV) outbreak in 2015–2016 were evaluated. Methods: This is a descriptive case 
series study of newborns whose mothers were suspected cases of ZIKV infections during their pregnancies. The medical records 
of all the suspected CZS cases (mothers and newborns) treated by the specialized ambulatory service from June 2015 to August 
2016 were analyzed. Results: Twenty suspected CZS cases were included in these analyses. They were categorized into four 
groups based on the clinical and laboratory findings: confirmed cases (n=1), highly probable cases (n=13), moderately probable 
cases (n=5), and somewhat probable cases (n=1). The mothers tested negative for STORCH (syphilis, toxoplasmosis, other 
infections, rubella, cytomegalovirus infection, and herpes simplex) and other important congenital infections; however, specific 
ZIKV tests were not performed during the study period. Microcephaly was observed in the majority of these newborns, and all 
the patients showed altered cranial computed tomography image findings. Extracranial abnormalities such as arthrogryposis, and 
otological and ophthalmological manifestations were also observed. Conclusions: Although ZIKV was not confirmed to cause 
the congenital malformations, this study demonstrated that the clinical and epidemiological findings associated with a STORCH 
exclusion strengthened the CZS diagnosis. The suspected cases in MT occurred simultaneously with the first CZS cases reported 
in Brazil, suggesting ZIKV circulation in the study region during the same period.
Keywords: Congenital Zika Syndrome. Epidemiology. Microcephaly. Mato Grosso. Zika virus.
INTRODUCTION
The Zika virus (ZIKV) is a mosquito-borne RNA virus 
belonging to the Flavivirus genus of the Flaviviridae family. This 
virus was initially isolated in 1947 from rhesus macaques in the 
Zika forest of Uganda. Subsequently, the ZIKV was associated 
with an acute febrile disease in humans with mild symptoms and 
no major intercurrences with other arbovirus diseases, such as 
dengue fever and yellow fever1,2. The ZIKV was first detected 
in Brazil during March 2015 as patients in the state of Bahia 
presented with dengue fever-like symptoms1. The autochthonous 
circulation and transmission of the ZIKV were confirmed in the 
country during April and May of the same year3,4.
The most commonly observed symptoms described for a 
ZIKV infection include fever, maculopapular rash, arthralgia, 
and conjunctivitis2. During the epidemic outbreak in Brazil, 
the most commonly observed signs and symptoms were 
exanthema followed by headache, fever, arthralgia, myalgia, 
lymphadenopathy, and joint swelling. Conjunctivitis and retro-
orbital eye pain were also reported5. During the ZIKV epidemic 
in Brazil, which occurred in 2015 and 2016, a notable increase 
in microcephaly cases was observed in newborns. Moreover, 
pregnant women who were symptomatic for ZIKV infections 
especially in the northeastern region of Brazil inferred the 
association between this infection and the appearance of 
neurological abnormalities in their newborns6,7.
In addition to epidemiological evidence, laboratory findings 
were also associated with different imaging study patterns, 
reinforcing ZIKV infection as a causative agent for these 
congenital abnormalities. Additionally, the ZIKV genome was 
identified in samples collected from patients with microcephaly 
2/8
Roma JHF et al. - Congenital Zika Syndrome case series
and other malformations during pregnancy and after delivery, 
and this was extensively documented8-10. The size and severity of 
the outbreak and its link to congenital transmission led the World 
Health Organization to declare the infection as a public health 
emergency of international importance in February of 201611.
Recent studies have shown that microcephaly is not the only 
condition caused by congenital Zika syndrome (CZS). Even 
though it is the most dramatic finding, numerous neurological 
and motor abnormalities such as arthrogryposis, delayed 
neuropsychomotor development, intrauterine growth restriction, 
otological and ophthalmological manifestations, and Guillain-
Barré syndrome can also occur12,13.
Given this context, the objective of this study was to evaluate 
the clinical and epidemiological data obtained from newborn 
babies with suspected CZS in the southern Mato Grosso (MT) 
region of Brazil during the 2015–16 ZIKV outbreak.
METHODS
This descriptive case series study focuses on a group of 
newborn babies with suspected CZS. Their mothers were likely 
to be infected by ZIKV during their pregnancies, which occurred 
during the 2015–16 Brazilian epidemic. The newborn babies were 
accompanied by the Specialized Ambulatory Service (SAS) of the 
Rondonópolis municipality in MT from June 2015 to August 2016. 
All the medical records of the suspected cases were evaluated.
During the outbreak, pregnant women who presented with 
ZIKV infection symptoms were referred to the Municipal Health 
Division, which conducted a rigorous pregnancy follow-up. All 
the newborn babies with suspected CZS were referred to the 
SAS. At the health center, these babies were followed up by a 
pediatric physician specializing in infectious diseases as part 
of the clinical routine established by the Brazilian Ministry of 
Health protocols. The differential diagnosis was based on the 
clinical findings of CZS characteristics, family history, and 
laboratory tests for the main congenital infections affecting the 
central nervous system (CNS), as well as ultrasound, magnetic 
resonance imaging, and computed tomography (CT) findings.
Initially, 41 medical records were included in this study. 
Case selection was based on the following inclusion criteria: 
CZS suspicion or a microcephaly diagnosis confirmed by 
an ultrasound examination during pregnancy or at birth, 
with findings suggestive of a congenital infection. The cases 
were defined as probable CZS according to the protocol for 
surveillance and response to the occurrence of microcephaly 
and/or CNS Alterations of the Brazilian Ministry of Health7.
The CZS cases that were included were classified into four 
groups (adapted from França et al.)14: 
1. Confirmed cases, as defined by laboratory evidence of a ZIKV 
infection via an immunological examination (immunoglobulin 
M, IgM) or ZIKV genome detection using reverse transcriptase 
– polymerase chain reaction (RT-PCR) in a maternal or newborn 
sample.
2. Highly probable cases, as defined by neuroimaging findings 
suggestive of CZS, associated with negative STORCH 
laboratory results (syphilis, toxoplasmosis, others such as 
varicella-zoster and parvovirus B19, rubella, cytomegalovirus 
infection, and herpes simplex).
3. Moderately probable cases, as defined by neuroimaging findings 
suggestive of CZS and incomplete or nonexistent STORCH 
testing.
4. Somewhat probable cases, as defined by neuroimaging 
findings with little detail and a negative STORCH diagnosis or 
nonexistent STORCH testing. 
When considering other possible CNS malformation 
causes, the following exclusion criteria were defined: positive 
serological STORCH results associated with a negative 
diagnosis for the ZIKV in a maternal or newborn sample, the 
diagnosis of a genetic syndrome identified during prenatal 
care or after birth, medical records with missing data, newborn 
prenatal and perinatal complications, and exposure to licit or 
illicit drugs or teratogenic substances during pregnancy.
Ethical considerations
All data described in this report were collected from medical 
records, and this study was approved by the Ethics Committee 
of the Research of the Federal University of Mato Grosso in 
Brazil (ECR 87100418.6.0000.8088).
RESULTS
Forty-one newborn babies from the Rondonópolis maternity 
ward were referred to the SAS owing to suspicion of CZS 
from June 2015 to August 2016. The medical follow-ups were 
performed as indicated previously, and all the data were registered 
in the SAS medical records. After considering the inclusion and 
exclusion criteria, twenty of the forty-one medical records were 
included in the data analyses. Among the excluded cases two 
were diagnosed with genetic syndromes, three had confirmed 
congenital toxoplasmosis based on serological testing, and the 
sixteen remaining patients either had incomplete medical records 
without imaging evaluations or laboratory test results, or due to 
lack of medical follow-ups at the healthcare center.
A ZIKV laboratory diagnosis was not fully available in Brazil 
during the beginning of the epidemic. Hence, a case classification 
into four CZS groups was proposed based on the clinical and 
laboratory findings. In our study, only one suspected case was 
confirmed through positive findings for IgM antibodies against 
the ZIKV, and this case corresponded to Group One (confirmed 
cases). The highly probable CZS case group had thirteen 
newborn babies who were included in Group Two. Five children 
were classified into Group Three, i.e., they had  moderately 
probable CZS. Finally, only one patient was considered as 
somewhat probable CZS case (Group Four) (Tables 1 and 2).
The mothers’ sociodemographic characteristics, obstetric 
histories, and prenatal care data were self-reported and analyzed 
(Table 1). In the cohort, there were several young mothers, 
with a mean age of ~24.35 years old [standard deviation (SD) 
4.82 years]. The youngest mother was 18 years old, while 
the oldest was 30 years old. With regard to skin color, the 
majority of the mothers was brown (fifteen mothers). The 
mean family income was ~1.45 times the Brazilian minimum 
wage (BMW), which corresponds to R$880 (Brazilian reals) 
or approximately $233.57 (US dollars). The lowest income 
reported was 0.6 times the BMW, while the highest was 3.4 times 
the BMW. Four of the mothers reported the continuous use of 
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drugs/medications during pregnancy. Only four mothers were 
reported to be primiparous. Eight of the mothers had at least 
one previous abortion, and three of the mothers were exposed 
to x-rays during pregnancy. Thirteen of the women presented 
with maternal complications during pregnancy and the most 
frequently seen complications were urinary tract infections 
(eight), oligohydramnios (six), maternal anemia (four), placenta 
alterations (three), and gestational diabetes (one) (Table 1).
During the study period, serological or RT-PCR tests specific 
to the ZIKV were not used to diagnose in all the mothers during 
or following pregnancy. All 41 mothers referred to the SAS had 
associations with ZIKV infections during their pregnancies, with 
or without clinical signs. Of the twenty babies included in the 
study, thirteen mothers reported clinical symptoms of ZIKV 
infection especially cutaneous rashes during their pregnancies 
(Table 1). 
When analyzing the newborn data, all the clinical and 
laboratory data were registered in the medical records by 
the SAS medical staff. The data analyses of this information 
(Tables 2 and 3) showed an equal gender distribution among the 
CZS cases: ten female and ten male cases. The mean gestational 
age at birth was ~37.05 weeks (SD 2.25 weeks), with the lowest at 
30 weeks and the highest at 40 weeks. Most patients (80%) were 
born via cesarean sections (16/20). Half of the births occurred at 
the end of 2015, during November (five births) and December 
(five births). The mean birth weight among the newborns was 
2,458 g (SD 0.62 g). Nine of the newborns had low birth weights 
(< 2,500 g), and one had a very low birth weight (< 1,500 g) 
(Table 3). The occurrence of microcephaly was considered to 
be a hallmark of CZS in this study, and it affected the majority 
of newborns (Table 3). The mean head circumference (HC) at 
birth was ~29.5 cm (SD 2.48 cm), the lowest and highest being 
24 cm and 34 cm, respectively. The HC z-score was calculated 
according to the standards/references of the International Fetal 
and Newborn Growth Consortium for the 21st Century newborn 
biometry, which considered the sex, gestational age at birth, 
height, and weight (Table 2). The mean HC z-score was -2.35 
(SD 1.93); the lowest was -4.25, and the highest was 0.79 
(Table 2). In most patients, the microcephaly diagnosis 
(mean z-score of < -2.0) occurred after birth, and six of 
these cases had severe microcephaly (mean z-score of < -3.0) 
(Tables 2 and 3). 
Specific ZIKV laboratory analyses were not performed in 
all patients. Only seven patients were tested for ZIKV; one of 
them had positive IgM serology results, and this was the only 
laboratory-confirmed case. The other six serum samples were 
submitted for RT-PCR testing, and all the samples were found 
to be negative for the ZIKV genome.
All newborns included in this study underwent a cranial 
CT scan, and all the patients exhibited alterations in the 
image analyses. The main imaging findings and frequencies 
are described in Table 3. Electroencephalogram analyses 
were only performed in eight patients, and all cases presented 
abnormal tracing with dyssynchronous activity, characteristic 
graphs of cerebral irritability, and nonspecific pathological 
slowing (Table 2).
The extracranial examinations were performed according 
to the protocol of the Brazilian Ministry of Health. Therefore, 
abdominal ultrasounds were conducted in ten patients, all 
of whom presented normal results. Sixteen of the patients 
underwent echocardiography, three of them had patent oval 
foramen, and two had interatrial communications. Neonatal 
hearing screenings were performed in all patients, and five 
of them presented with hearing losses ranging from moderate 
to severe. Fourteen of the newborn babies underwent 
ophthalmological assessments, and some abnormalities were 
observed in two patients (Table 2). The other extracranial 
malformations are summarized in Table 3.
DISCUSSION
The impact of the ZIKV epidemic in Brazil is mainly 
related to the occurrence of CZS, which leads to profound 
neurodevelopmental impairments in the affected children. Our 
study described data from the first suspected cases of congenital 
alterations related to maternal ZIKV infections in the southern 
region of MT in west central Brazil in November of 2015, 
revealing fifty-four suspected cases concentrated within the 
southern region15,16. The clinical and epidemiological findings 
presented in this study support the simultaneous introduction of 
the ZIKV and the occurrence of CZS cases in the northeastern14, 
central western, and other regions of Brazil based on the date 
of birth of the first suspected case in this region in June of 
2015. The mother reported a skin rash in May 2015, but had no 
travel history during her pregnancy. Thus, the maternal ZIKV 
infection symptoms were observed at approximately 26–27 
weeks of pregnancy, while CZS was present at birth inferring 
that the maternal infection was an autochthone case in our 
study. Although this case was not confirmed by molecular or 
serological testing, it was considered to be a highly probable 
case because the STORCH results were negative, and the case 
exhibited imaging findings, such as calcifications, cerebral 
atrophy, and ventriculomegaly. These data strengthened the 
diagnosis of CZS.
A nonuniform profile in the geographical distribution of 
CZS cases throughout the national territory was observed. 
From 2015 to 2016, 2,176 suspected CZS cases were reported 
in Pernambuco, which represented 21.3% of the Brazilian 
cases. At the same time, only 319 cases were reported in MT 
(3.1%)17. Therefore, an unusually higher number of CZS 
cases were concentrated in the northeast when compared to 
the central western region, which might be explained by the 
higher Aedes aegypti (the principal ZIKV vector) infestation 
risk related to increased poverty and an elevated demographic 
density18. The increase in the principal vector number, which is 
associated with high demographic indices, could facilitate the 
spread of the ZIKV. Moreover, poverty contributes to the vector 
proliferation, malnutrition, and poor health which together can 
affect the immunity and increase the risk of ZIKV infections 
and CZS cases.
The social data analysis of the mothers who self-reported 
demonstrated that they earned less than two times the BMW 
family income and lacked proper education reflecting a fragile 
Rev Soc Bras Med Trop Vol.:52:e20190105, 2019
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TABLE 3: Epidemiological and clinical data classification based on the presence of microcephaly.
Normal HCa (n=6)
nº positive/nº tested
Microcephalya (n=8)       
nº positive/nº tested
Severe Microcephalya (n=6)     
nº positive/nº tested
Classification of Cases
Confirmed 1/6 - -
Highly probable cases 3/6 6/8 4/6
Moderate probable cases 1/6 2/8 2/6
Somewhat probable cases 1/6 - -
Sex 
Male (n=10) 2 4 4
Female (n=10) 4 4 2
Gestational age of newborn
At term, 37 at 41 weeks and 6 days 5/6 5/8 3/6
Preterm, < 37 weeks 1/6 3/8 3/6
Post term, ≥ 42 weeks - - -
Weight for gestational age
      Normal 6/6 8/8 4/6
      Small for gestational age - - 2/6
Birthweight
<1500 g - - 1
1500 – 2499 g 3 3 3
≥ 2500 g 3 5 2
Mother self-reported rash during pregnancy (n=20)
No rash 2/6 3/8 2/6
First Trimester 2/6 3/8 2/6
Second Trimester 2/6 1/8 2/6
Third Trimester - 1/8 -
Zika Virus Laboratorial Test in Newborn
RT-PCR (n=6) -/2 -/1 -/3
ELISA IgM (n=1) 1/1 - -
Brain abnormal findings in CT or MRI (n=20) 6/6 8/8 6/6
Abnormal findings in TU (n=7) -/1 3/4 2/2
Abnormal findings in Ophthal Evaluation (n=14) -/3 1/7 1/5
Abnormal findings in NHS (n=19) -/5 2/8 3/6
Main cranial imaging findings
Calcifications 5/6 7/8 6/6
Malformation of cortical development, including 
lissencephaly
1/6 8/8 2/6
White substance hypodensity 2/6 1/8 -/6
Ventriculomegalia 1/6 6/8 4/6
Agenesis/dysgenesis of corpus callosum - 5/8 1/6
Subarachnoid Spaces Prominence - 1/8 1/6
Hydrocephalus 1/6 1/8 -/6
Myelination Failure 1/6 - -
Craniofacial Disproportion 4/6 8/8 6/6
Main extracranial findings
Anemia 3/6 1/8 2/6
Arthrogryposis 1/6 - -
Auricular System Alteration - 1/8 -
Circulatory System Alteration 1/6 - 2/6
Jaundice 3/6 3/8 6/6
Sickle cell trait 1/6 - -
ameasured at birth; HC: Head Circumference; CT: Computed Tomography; MRI: Magnetic Resonance Imaging; RT-PCR: Reverse Transcriptase-Polymerase 
Chain Reaction; NHS: Neonatal Hearing Screening; TU: Transfontanela Ultrasound.
socioeconomic background. Only four mothers reported the use 
of drugs and fetal development was not affected in these reported 
cases. The most commonly seen maternal complication during 
pregnancy was the presence of oligohydramnios (six cases), 
which was also described as having a possible relationship with 
a ZIKV infection in others studies19.
The majority of the suspected cases in our study was not 
confirmed by specific serological or molecular diagnostic testing 
because no standard or commercial tests were available during 
ZIKV introduction in Brazil. Only one child in this study had a 
laboratory confirmation of a ZIKV infection using an enzyme-
linked immunosorbent assay (ELISA) IgM detection. An ELISA 
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test can exhibit a cross reaction with other arboviruses, such 
as those causing dengue fever and yellow fever; however, the 
CZS diagnosis in this case was determined by the clinical and 
epidemiological features20. According to their medical records, 
RT-PCR was performed using the serum of six newborns, 
and none of the samples tested positive for the viral genome. 
Although the persistent detection of ZIKV RNA has been 
described in the cerebrospinal fluid and blood samples of an 
infant with CZS21, the negative results observed in our study 
may be explained by certain limitations, such as the kinetics of 
viremia, viral RNA degradation during sample processing and 
storage, and the limited RT-PCR sensitivity. The data obtained 
from the medical records of the other newborns in our study 
showed that the specimens were not submitted for molecular 
investigations, probably due to the late maternal ZIKV infection 
period, the unavailability of a diagnostic facility, or even 
neglecting the ZIKV as a causative agent at the time of birth. 
In this emerging CZS epidemic scenario, without 
confirmatory and ZIKV-specific diagnostic tools, this study 
adopted a classification based on epidemiological data, clinical 
features, and the exclusion of positive STORCH results obtained 
from the medical records of the children and their respective 
mothers. This classification is similar to the one adopted by 
França et al.14, and it might be useful for further retrospective 
analyses, such as the one proposed by this study. Except for only 
one confirmed case, all patients in this study were classified as 
having highly, moderately, and somewhat probable CZS cases.
The patients who did not undergo specific confirmatory tests 
and those who had negative RT-PCR results were classified 
as highly probable cases with the exclusion of congenital 
malformations due to STORCH, genetic, and teratogenic drugs. 
When the STORCH causes were not excluded, the moderately 
probable case classification was adopted, because even when 
presenting imaging findings suggestive of CZS associated with 
ZIKV symptoms during pregnancy (four to five mothers), it is 
not possible to exclude other congenital infectious diseases that 
are also endemic to the study region.
According to the Brazilian Ministry of Health guidelines7, 
the highly and moderately probable cases in this study were 
defined as Confirmed Cases of Congenital Infection without 
Etiological Identification. This classification includes newborns 
or stillbirths with clinical findings suggestive of a maternal 
infection, maternal exanthema, or unspecified fever, with 
inconclusive or negative results for the STORCH and ZIKV 
tests. The significant 134% increase in microcephaly reports 
in November and December 2015 and the microcephaly 
occurrences (14 cases) in the study reinforce our classification 
focused on CZS based on epidemiological and clinical data15.
The initial clinical evaluation of the only somewhat probable 
case revealed an absence of microcephaly and little detailed 
neuroimaging findings, which included periventricular white 
matter hyposensitivity without calcifications. Moreover, this 
newborn presented incomplete STORCH results and no maternal 
skin rash was observed during pregnancy. Although this 
newborn was considered to have suspected CZS, more detailed 
information about congenital alterations should be determined 
in order to confirm this diagnosis.
According to CZS data, most of our patients presented 
morphological CNS alterations, including microcephaly (2 
SDs below the mean) and severe microcephaly (3 SDs below 
the mean), cortical and subcortical junction calcifications, and 
other encephalic anomalies, which are followed by ocular 
failing, hearing loss, and craniofacial disproportion22. Even 
though microcephaly was initially characterized as the main 
finding of CZS, new reports have shown other CNS deformities 
that are not visible in the absence of microcephaly13. Some of 
the patients in our study did not present with microcephaly, 
although encephalic injury was reflected by microcalcifications, 
lissencephaly, ventriculomegaly, white substance hypodensity, 
myelination defects, and corpus callosum dysgenesis, which 
corroborates early reports. It is important to highlight that all 
these forms of CNS impairment are commonly observed in 
CZS but are not pathognomonic, and they can be observed 
in other congenital syndromes20. In addition, isolated HC 
measurement is an ambiguous parameter for determining 
the presence of microcephaly; other CNS imaging findings 
associated with craniofacial disproportion should be also 
considered. This was observed in the only confirmed CZS 
case (patient one, Table 2), in which the HC measurement was 
considered to be at the inferior limit of normality, but significant 
craniofacial disproportion was observed, leading to the clinical 
characterization of CZS. Other highly probable cases showed 
similar data (patients five and eight, Table 2). Moreover, the 
study cases presented other important clinical findings, such 
as low birthweights, arthrogryposis23,24, circulatory system 
alterations, irritability, jaundice, anemia, and sickle cell traits. 
In conclusion, the evaluation of the clinical and 
epidemiological data associated with the adopted classification 
strengthened the CZS diagnosis in the study cases, even without 
confirmatory maternal ZIKV infection results. Furthermore, 
these cases occurred simultaneously with the first reported CZS 
cases in Brazil, suggesting ZIKV circulation in the southern 
region of MT in 2015. Inexpensive diagnostic tools, vaccine 
development, and vector control are essential for preventing 
future outbreaks and reducing the effect of CZS on newborns 
and children. Furthermore, medical and psychological support 
for mothers and their affected children is indispensable.
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